We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Colgate (CL) Benefits From Innovation and Pricing Strategies
Read MoreHide Full Article
Colgate-Palmolive Company (CL - Free Report) is well-placed for long-term growth backed by its business strategy of increasing its leadership in key product categories through innovation in core businesses, tracking adjacent categories’ growth and expansion into new markets and channels. CL has been ranked the leading consumer goods company, with a global household penetration of 61.6%.
Aggressive pricing actions and robust consumer demand, along with solid business momentum, have been the key to the earnings success of this global leader in the oral care hygiene market. In addition, accelerated revenue growth management plans have been bolstering organic sales of Colgate, with first-quarter 2024 organic sales increasing 9.8%.
Shares of this current Zacks Rank #3 (Hold) company have gained 24.1% in the past year compared with the industry’s 13.5% growth. The consumer goods company also compared favorably with the sector’s decline of 3.6%.
The Zacks Consensus Estimate for CL’s current financial-year sales and earnings indicates growth of 3.9% and 9.3%, respectively, from the year-ago reported numbers.
Image Source: Zacks Investment Research
What Places CL Well?
Colgate-Palmolive has been gaining from continued strong pricing and the benefits of funding growth and other productivity initiatives. It has been implementing aggressive pricing for the last few quarters, which boosted margins in first-quarter 2024.
The company has adopted aggressive pricing mainly to combat the inflation in raw materials, particularly agricultural products. Colgate, on its last reported quarter’s earnings call, revealed its expectations to witness a moderation in agricultural prices going into 2024. Consequently, it anticipates a moderation in the pricing for its products and a rebound in volume growth, thereby driving household penetration in its markets.
In the quarters ahead, CL foresees gross profit margin expansion on both GAAP and adjusted basis, driven by continued pricing gains, benefits from revenue growth management initiatives and strength in the funding-the-growth program.
Colgate continues to witness market share momentum, backed by strong innovation and higher levels of brand investment, with a focus on enhancing the efficacy of every dollar spent. The company’s innovation strategy is focused on growing in adjacent categories and product segments. It is also focused on the premiumization of its Oral Care portfolio through major innovations.
Additionally, CL’s progress on its digital transformation endeavors, along with the finest data analytics, bodes well for continued improvement in revenues and profitability. We are also optimistic about the company’s revenue growth management initiatives, which will position it well for growth in several quarters ahead.
Hiccups
Colgate has been witnessing headwinds related to inflation and the challenging macroeconomic environment. Raw material inflation and the continued rise in packaging have been acting as a deterrent to the company’s profitability. Continued volume softness in China and the headwind from lower private label growth with the transfer of more of Hill’s volume into the pet nutrition manufacturing network also impacted sales in the recent quarters.
Also, the foreign currency fluctuations are concerning. The sales view for 2024 includes a mid-single-digit negative impact of currency.
Stocks to Consider
We have highlighted three better-ranked stocks from the Consumer Staple sector, namely Freshpet (FRPT - Free Report) , Vital Farms (VITL - Free Report) and PepsiCo Inc. (PEP - Free Report) .
Freshpet is a pet food company. The company manufactures and markets natural fresh foods, refrigerated meals, and treats for dogs and cats in the United States and Canada. It has a trailing four-quarter earnings surprise of 118.2%, on average. FRPT currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Freshpet’s current financial-year sales and earnings indicates growth of 24.8% and 177.1%, respectively, from the prior-year reported level.
Vital Farms offers a range of produced pasture-raised foods. VITL currently sports a Zacks Rank of 1. It has a trailing four-quarter earnings surprise of 102.1%, on average.
The consensus estimate for Vital Farms’ current financial year’s sales and earnings per share indicates growth of 22.5% and 59.3%, respectively, from the year-ago reported figures.
PepsiCo, a leading global food and beverage company, currently carries a Zacks Rank #2 (Buy). PEP has a trailing four-quarter earnings surprise of 5.1%, on average.
The Zacks Consensus Estimate for PEP’s current financial-year sales and earnings indicates growth of 3.6% and 7.1%, respectively, from the year-earlier actuals.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Colgate (CL) Benefits From Innovation and Pricing Strategies
Colgate-Palmolive Company (CL - Free Report) is well-placed for long-term growth backed by its business strategy of increasing its leadership in key product categories through innovation in core businesses, tracking adjacent categories’ growth and expansion into new markets and channels. CL has been ranked the leading consumer goods company, with a global household penetration of 61.6%.
Aggressive pricing actions and robust consumer demand, along with solid business momentum, have been the key to the earnings success of this global leader in the oral care hygiene market. In addition, accelerated revenue growth management plans have been bolstering organic sales of Colgate, with first-quarter 2024 organic sales increasing 9.8%.
Shares of this current Zacks Rank #3 (Hold) company have gained 24.1% in the past year compared with the industry’s 13.5% growth. The consumer goods company also compared favorably with the sector’s decline of 3.6%.
The Zacks Consensus Estimate for CL’s current financial-year sales and earnings indicates growth of 3.9% and 9.3%, respectively, from the year-ago reported numbers.
Image Source: Zacks Investment Research
What Places CL Well?
Colgate-Palmolive has been gaining from continued strong pricing and the benefits of funding growth and other productivity initiatives. It has been implementing aggressive pricing for the last few quarters, which boosted margins in first-quarter 2024.
The company has adopted aggressive pricing mainly to combat the inflation in raw materials, particularly agricultural products. Colgate, on its last reported quarter’s earnings call, revealed its expectations to witness a moderation in agricultural prices going into 2024. Consequently, it anticipates a moderation in the pricing for its products and a rebound in volume growth, thereby driving household penetration in its markets.
In the quarters ahead, CL foresees gross profit margin expansion on both GAAP and adjusted basis, driven by continued pricing gains, benefits from revenue growth management initiatives and strength in the funding-the-growth program.
Colgate continues to witness market share momentum, backed by strong innovation and higher levels of brand investment, with a focus on enhancing the efficacy of every dollar spent. The company’s innovation strategy is focused on growing in adjacent categories and product segments. It is also focused on the premiumization of its Oral Care portfolio through major innovations.
Additionally, CL’s progress on its digital transformation endeavors, along with the finest data analytics, bodes well for continued improvement in revenues and profitability. We are also optimistic about the company’s revenue growth management initiatives, which will position it well for growth in several quarters ahead.
Hiccups
Colgate has been witnessing headwinds related to inflation and the challenging macroeconomic environment. Raw material inflation and the continued rise in packaging have been acting as a deterrent to the company’s profitability. Continued volume softness in China and the headwind from lower private label growth with the transfer of more of Hill’s volume into the pet nutrition manufacturing network also impacted sales in the recent quarters.
Also, the foreign currency fluctuations are concerning. The sales view for 2024 includes a mid-single-digit negative impact of currency.
Stocks to Consider
We have highlighted three better-ranked stocks from the Consumer Staple sector, namely Freshpet (FRPT - Free Report) , Vital Farms (VITL - Free Report) and PepsiCo Inc. (PEP - Free Report) .
Freshpet is a pet food company. The company manufactures and markets natural fresh foods, refrigerated meals, and treats for dogs and cats in the United States and Canada. It has a trailing four-quarter earnings surprise of 118.2%, on average. FRPT currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Freshpet’s current financial-year sales and earnings indicates growth of 24.8% and 177.1%, respectively, from the prior-year reported level.
Vital Farms offers a range of produced pasture-raised foods. VITL currently sports a Zacks Rank of 1. It has a trailing four-quarter earnings surprise of 102.1%, on average.
The consensus estimate for Vital Farms’ current financial year’s sales and earnings per share indicates growth of 22.5% and 59.3%, respectively, from the year-ago reported figures.
PepsiCo, a leading global food and beverage company, currently carries a Zacks Rank #2 (Buy). PEP has a trailing four-quarter earnings surprise of 5.1%, on average.
The Zacks Consensus Estimate for PEP’s current financial-year sales and earnings indicates growth of 3.6% and 7.1%, respectively, from the year-earlier actuals.